ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

MOR MorphoSys AG

18.39
0.03 (0.16%)
01 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
MorphoSys AG MOR 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.03 0.16% 18.39 05:30:00
개장가 저가 고가 종가 전일 종가
18.33 18.29 18.41 18.39 18.36
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
31/05/202423:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/05/202423:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/05/202423:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/05/202423:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/05/202403:19EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
23/05/202423:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/05/202422:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/05/202423:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/05/202423:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/05/202405:43EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
16/05/202423:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/05/202423:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/05/202423:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/04/202405:01BWMorphoSys AG Reports First Quarter 2024 Financial Results
11/04/202421:39BWMorphoSys’ Management Board and Supervisory Board Recommend..
14/03/202405:02BWMorphoSys AG Reports Fourth Quarter and Full Year 2023..
06/02/202420:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
11/12/202309:31BWMorphoSys’ Pelabresib Improves All Four Hallmarks of..
21/11/202307:19DJNMorphoSys Trial for Blood-Cancer Treatment Reaches Primary..
21/11/202306:30BWMorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis..
16/11/202306:01BWMorphoSys AG Reports First Nine Months and Third Quarter..
10/08/202305:01BWMorphoSys AG Reports Second Quarter and First Half 2023..